Search

everythinglearnresearchcommunity

for

Search:↓

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

New pyrazole derivatives may help treat hair loss, but more testing is needed.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

A CCS patient with severe complications was successfully treated using combined therapies.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Switching to generic tacrolimus was safe, effective, and saved money.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Upadacitinib may effectively treat resistant lichen planopilaris.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Baricitinib is effective as a treatment for severe hair loss.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

New minoxidil compounds with better water solubility were made, but their full effects and safety need more research.

New retinoids are effective for various skin conditions and are being developed to have fewer side effects.

Adapalene, Diosmin, and Azelastine could be repurposed to treat onchocerciasis.

Pantethine may boost the immune system's ability to fight sarcoma.

New substances were created that improve health and may treat dementia, osteoporosis, and cancer.